(Q36268296)

13 August 2017

1 reference

title

The role of the sympathetic nervous system in controlling bone metabolism (English)

1 reference

13 August 2017

Akifumi Togari

1

1 reference

13 August 2017

Michitsugu Arai

series ordinal

2

1 reference

13 August 2017

Ayami Kondo

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Expert Opinion on Therapeutic Targets

13 August 2017

published in

1 reference

13 August 2017

volume

9

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

931-940

1 reference

Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Microisolated mouse osteoclasts express VIP-1 and PACAP receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Expression of mRNA for axon guidance molecules, such as semaphorin-III, netrins and neurotrophins, in human osteoblasts and osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Leptin regulates bone formation via the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Effects of beta-adrenergic blockade in an osteoblast-like cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Catecholamines modulate growth and differentiation of human preosteoclastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Effect of surgical sympathectomy on bone remodeling at rat incisor and molar root sockets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Activation of the peripheral sympathetic nervous system increased the expression of cyclooxygenase-2 (COX-2) mRNA in mouse calvaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Leptin regulation of bone resorption by the sympathetic nervous system and CART

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Mechanism of action of amylin in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Sympathetic nervous system as transmitter of mechanical loading in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Effects of propranolol on bone metabolism in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Inhibited longitudinal growth of bones in young male rats by clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Influence of clenbuterol on bone metabolism in exercised or sedentary rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Use of beta-blockers and risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Fracture risk in perimenopausal women treated with beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Sex hormones and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Duration of menopause and behavior of malondialdehyde, lipids, lipoproteins and carotid wall artery intima-media thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Age and gender influence muscle sympathetic nerve activity at rest in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

Neuro-immune-endocrine functional system and vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.931

21 January 2018

Identifiers

DOI

10.1517/14728222.9.5.931

1 reference

release_e3fhbn5zqvesfpz5zoujvq5sj4

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e3fhbn5zqvesfpz5zoujvq5sj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference